Many scleroderma patients die early in the course of the disease, and studies that measure mortality without taking that into consideration tend…
Magdalena Kegel
Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Magdalena Kegel
Current methods of dividing scleroderma patients into groups, based on characteristics of their disease in order to predict its likely progression,…
Therapeutic plasma exchange (TPE) has the potential to treat digital ulcers and Raynaud’s symptoms in patients with scleroderma, as recently…
Problems with the esophagus that result in difficulties with swallowing, or regurgitation and heartburn, typically affect “only one-third” of scleroderma patients, a…
Stimulating skin fat stem cells eased skin fibrosis in a scleroderma mouse model, suggesting the treatment may be an option for patients. Injections…
An overview of published studies exploring the use of therapeutic plasma exchange (TPE) in scleroderma patients indicated that the treatment improved Raynaud’s…
Researchers have identified risk factors of pulmonary arterial hypertension (PAH) in patients with scleroderma, showing that the risk profiles differ…
Resunab, Potential Scleroderma Treatment, Shows Ability to Stop Inflammation in Early Clinical Trial
Corbus Pharmaceuticals reported new findings supporting the anti-inflammatory actions of its lead compound Resunab (JBT-101), which is currently…
Reliability of Rating Scleroderma Digital Ulcers Doesn’t Improve with More Clinical Information
Ratings of digital ulcers by rheumatologists tend to differ according to the clinician involved. But a new study reports that including…
Few scleroderma patients have antibodies directed specifically against the Ku antigen, but those who do, and have them as the…